News Conference News ESC Heart Failure 2025 TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal Todd Neale May 21, 2025
News Conference News HRS 2025 BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs Todd Neale May 02, 2025
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Daily News Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show Michael O'Riordan January 10, 2024
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Daily News Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor Michael O'Riordan April 12, 2019
News Daily News Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes Michael O'Riordan August 09, 2018